{
    "eid": "2-s2.0-85139299235",
    "title": "Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster",
    "cover-date": "2022-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Immunology and Microbiology (all)",
            "@code": "2400",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Veterinary (all)",
            "@code": "3400",
            "@abbrev": "VETE"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "BNT162b2",
        "Booster vaccination",
        "Inactivated COVID-19 vaccine",
        "SARS-CoV-2 antibody",
        "School-aged children"
    ],
    "authors": [
        "Napaporn Chantasrisawad",
        "Thanyawee Puthanakit",
        "Katesiree Kornsitthikul",
        "Peera Jaru-Ampornpan",
        "Monta Tawan",
        "Pariya Matapituk",
        "Jiratchaya Sophonphan",
        "Suvaporn Anugulruengkitt",
        "Auchara Tangsathapornpong",
        "Apirat Katanyutanon"
    ],
    "citedby-count": 1,
    "ref-count": 33,
    "ref-list": [
        "Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19-associated emergency department and urgent care encounters and hospitalizations among nonimmunocompromised children and adolescents aged 5\u201317 Years \u2013 VISION network, 10 States, April 2021-January 2022",
        "BNT162b2 protection against the omicron variant in children and adolescents",
        "Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age",
        "Effectiveness of 2-dose BNT162b2 (Pfizer BioNTech) mRNA vaccine in preventing SARS-CoV-2 infection among children Aged 5\u201311 years and adolescents aged 12\u201315 years \u2013 PROTECT Cohort, July 2021-February 2022",
        "Effectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the Omicron outbreak in Argentina",
        "Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant",
        "Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, andomized study",
        "Safety and immunogenicity of a booster vaccination by coronavac or BNT162b2 in previously two-dose inactivated virus vaccinated individuals with negative neutralizing antibody",
        "Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study",
        "Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19",
        "A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction",
        "Chimeric virus-like particle-based COVID-19 vaccine confers strong protection against SARS-CoV-2 viremia in K18-hACE2 mice",
        "Pseudotype neutralization assays: from laboratory bench to data analysis",
        "A single-cycle influenza a virus-based SARS-CoV-2 vaccine elicits potent immune responses in a mouse model",
        "Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection",
        "A serological assay to detect SARS-CoV-2 seroconversion in humans",
        "Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support",
        "The REDCap consortium: building an international community of software platform partners",
        "Dynamics of neutralizing antibody and T-cell responses to SARS-CoV-2 and variants of concern after primary immunization with coronavac and booster with BNT162b2 or ChAdOx1 in health care workers",
        "Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": null,
            "@id": "60029201",
            "affilname": "Chonburi Regional Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029201",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nontaburi",
            "@id": "60015728",
            "affilname": "Thailand Ministry of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015728",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60013939",
            "affilname": "Faculty of Medicine, Thammasat University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013939",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60011947",
            "affilname": "Thailand National Center for Genetic Engineering and Biotechnology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011947",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Center of Excellence in Pediatric Infectious Diseases and Vaccines",
        "Chonburi Provincial Public Health Office",
        "Department of Diseases Control",
        "National Vaccine Institute, Thailand",
        "Chulalongkorn University",
        "Ministry of Public Health, Thailand",
        "Thammasat University"
    ]
}